Loading bill breakdown…
H.R. 2821119th CongressHealth
FDA Modernization Act 3.0
Sponsored by Rep. Earl L. "Buddy" Carter (R-GA) · 41 active : 20 Republicans, 21 Democrats
Latest action: Received in the Senate.
Where it standsPassed House, now in the Senate7 senators score as swing votes
Passed House
- House: passedJul 20, 2026
- Senate: next
- President: not yet
Summary
, via Congress.govFDA Modernization Act 3.0
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.
The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications.
Read full summaryHide full summary
The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
Committees and subjects
Committees
- House Committee on Energy and Commerce · HouseReported by · Markup by · Referred to
- Health · HouseReported by · Markup by · Referred to
Subjects
- Administrative law and regulatory procedures
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Medical research
- Research administration and funding
How the Senate breaks down
- 7Swing 70–100
- 65Middle 30–70
- 28Entrenched 0–30
Members fall into . All 100 senators have enough data to score.
Key players in the Senate
Ranked by swing score, 0–100 · swing-v2Bars show each input from 0 to 100: ideology gap, scorecard gap, . is the seat’s partisan lean, and shows how much of the input data a score has.
Similar past votes, Senate
Earlier behind swing-v3’s inputLoading similar votes
Cosponsors
41 activeShow all 41 cosponsors
- Diana Harshbarger (R-TN-1)
- Nanette Diaz Barragán (D-CA-44)
- Rosa L. DeLauro (D-CT-3)
- Troy A. Carter (D-LA-2)
- Vern Buchanan (R-FL-16)
- Lloyd Doggett (D-TX-37)
- Brian K. Fitzpatrick (R-PA-1)
- Dan Crenshaw (R-TX-2)
- Jerrold Nadler (D-NY-12)
- Mike Carey (R-OH-15)
- Nicole Malliotakis (R-NY-11)
- Daniel S. Goldman (D-NY-10)
- Darren Soto (D-FL-9)
- Hillary J. Scholten (D-MI-3)
- Judy Chu (D-CA-28)
- Jay Obernolte (R-CA-23)
- Josh Gottheimer (D-NJ-5)
- Jason Crow (D-CO-6)
- Ted Lieu (D-CA-36)
How the swing score works
Ideology gapHow far a member’s DW-NOMINATE voting score sits from their party’s median in the same chamber.
Scorecard gapHow far their Heritage Action and LCV ratings stray from their party’s average, using the groups’ votes on similar bills where available.
Cross-pressureHow strongly their district or state leans toward the other party, from our own computed partisan lean.
Similar votesHow often they voted against their own party on earlier roll calls about this bill or similar ones.
Committee bonusMembers of the committees handling the bill decide whether it moves, so they get a boost.
Cosponsor checkThe sponsor and active cosponsors have already committed, so they drop toward entrenched.
